Ll. Ioannidesdemos et al., CHANGES IN MIC ALTER RESPONSES OF PSEUDOMONAS-AERUGINOSA TO TOBRAMYCIN EXPOSURE, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1365-1369
The pharmacokinetic parameters determining antibiotic efficacy are pea
k concentrations (C-max), minimum (trough) concentrations (C-min), and
area under the concentration-time curve (AUC), There is general agree
ment about the importance of C-max and AUC for aminoglycosides, but th
is is not so for maintenance of C With in vitro exposures modelling in
vivo administration, Pseudomonas aeruginosa reference strain ATCC 278
53 (MIC, 1 mg/liter) and a higher-MIC (relatively resistant) clinical
isolate (MIC, 4 mg/liter) were used to explore bacteriostatic and bact
ericidal outcomes. With P. aeruginosa ATCC 27853, kill followed a comp
lete bolus profile with a 30-min postdistribution peak (C-peak30) of 1
0 mg/liter. The clinical isolate required a C-peak30 bolus profile of
20 mg/liter for kill, and there was no difference between the efficaci
es of the bolus and infusion exposures. Bolus profiles that were trunc
ated at 8.5 h and producing sublethal effects were then combined with
a wide range of C(min)s, With a C-peak30 profile of 8 mg/liter, P. aer
uginosa ATCC 27853 showed a graded bacteriostatic response until a C-m
in of greater than or equal to 0.8 mg/liter, when complete kill result
ed. In contrast, bactericidal effects on the clinical isolate required
a C-peak30 profile of 18 mg/liter with a C-min of greater than or equ
al to 1.0 mg/liter, Therefore, C-min also contributes to the bacterici
dal effect of tobramycin, with requirements showing minor variation wi
th change in MIC. Dosing principles for relatively resistant (higher-M
IC) organisms are suggested from the data. Relatively higher aminoglyc
oside doses via infusion regimens are likely to be needed to generate
higher peak concentrations and higher AUC values necessary for bacteri
cidal effect in resistant organisms. Maintenance of trough concentrati
ons on the order of 1.0 mg/liter during the interdose interval will te
nd to guard against the possibility of inadequate peak and AUC exposur
es for kill.